ENDRA Life Sciences Inc. (NDRA) financial statements (2021 and earlier)

Company profile

Business Address 3600 GREEN COURT
ANN ARBOR, MI 48105
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,1746,4715,602
Cash and cash equivalents6,1746,4715,602
Receivables  7
Inventory, net of allowances, customer advances and progress billings11359192
Inventory11359192
Prepaid expense11714567
Other current assets13127314
Total current assets:6,5356,9505,882
Noncurrent Assets
Operating lease, right-of-use asset405
Property, plant and equipment236273242
Total noncurrent assets:641273242
TOTAL ASSETS:7,1767,2236,124
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,709975848
Accounts payable1,278631780
Employee-related liabilities952941
Interest and dividends payable10  
Other undisclosed accounts payable and accrued liabilities32531427
Debt364  
Total current liabilities:2,073975848
Noncurrent Liabilities
Long-term debt and lease obligation343  
Operating lease, liability343
Total noncurrent liabilities:343  
Total liabilities:2,416975848
Stockholders' equity
Stockholders' equity attributable to parent, including:4,7616,2485,275
Common stock110
Additional paid in capital49,93433,93923,171
Accumulated deficit(45,217)(27,692)(17,895)
Other undisclosed stockholders' equity attributable to parent44  
Total stockholders' equity:4,7616,2485,275
TOTAL LIABILITIES AND EQUITY:7,1767,2236,124

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
Revenues 6352
Revenue, net352
Cost of revenue
(Cost of Goods and Services Sold)
 (288)(173)
Other undisclosed gross profit 288 
Gross profit: 6179
Operating expenses(10,844)(9,025)(4,805)
Operating loss:(10,844)(9,019)(4,626)
Nonoperating expense(2,462)(777) 
Other nonoperating expense(107)(777) 
Interest and debt expense  (43)
Loss from continuing operations before equity method investments, income taxes:(13,306)(9,796)(4,669)
Other undisclosed loss from continuing operations before income taxes  (708)
Net loss attributable to parent:(13,306)(9,796)(5,377)
Preferred stock dividends and other adjustments(4,220)  
Net loss available to common stockholders, diluted:(17,526)(9,796)(5,377)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
Net loss:(13,306)(9,796)(5,377)
Comprehensive loss, net of tax, attributable to parent:(13,306)(9,796)(5,377)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: